Stock Information
Biontech SE (BNTX)
Ticker Symbol: BNTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $21,924.73 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -4.6995
Revenue (TTM): $9.94 M
Dividend Yield: N/A%
ROE: -6.05%
Latest News
-
BioNTech and DualityBio's Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer
Mon, Apr 13, 2026 9:18 AM
-
BIONTECH : Berenberg reaffirms its Buy rating
Mon, Apr 13, 2026 7:46 AM
-
Elon Musk Questions COVID-19 Vaccine Dosage, Says It Was 'Obviously Too High'
Mon, Apr 13, 2026 6:01 AM
-
Reported Saturday, BioNTech And DualityBio's Trastuzumab Pamirtecan Meets Primary Endpoint With 47.9% Confirmed ORR In HER2-Expressing Recurrent Endometrial Cancer Phase 2 Trial
Mon, Apr 13, 2026 2:14 AM
-
Trastuzumab pamirtecan meets primary efficacy endpoint in phase 2 endometrial cancer cohort
Mon, Apr 13, 2026 2:00 AM
Key Financials
Financial data not available
